Johnson & Johnson is trading at €231.70, up 3.09%, with the healthcare-sector rally supporting the move as investors rotate away from technology. - XLV is up 2.12%. - No verified company-specific announcement on October 20 explains the rise. Johnson & Johnson announced Q3 results and raised 2026 guidance on October 13; these are not a fresh catalyst for this session. - Available coverage also describes healthcare benefiting from rotation out of AI and technology stocks.